Raporty

8/2013 Significant agreement with the National Health Fund

The Management Board of Centrum Medyczne ENEL-MED S.A. would like to inform you that on 04 February 2013, ENEL-MED received the signed annex to the agreement with National Health Fund – Masovian Voivodeship Branch in Warsaw, laying down terms of financing of healthcare services including hospital treatment, for 2013. As a result of the aforementioned annex, the total value of agreements concluded between Centrum Medyczne ENEL-MED S.A. and the National Health Fund since publication of current report no. 02/2013 on 18 January 2013 reached PLN 7,808,445.50 net, and thus exceeded the threshold of 10% of the company’s equity.

In the period analysed, the largest agreement concluded with the National Health Fund was an annex to the agreement of significant value of PLN 5,130,570.00 net that the Company received on 04 February 2013.

The subject of the annex, constituting an agreement with the National Health Fund, is provision of healthcare services as hospital treatment in the area of neurosurgery, orthopaedics, general surgery, otolaryngology, ophthalmology and vascular surgery. The aforementioned medical services will be provided in two hospitals of Centrum Medyczne ENEL-MED located in Warsaw: Centre Hospital (neurosurgery and orthopaedics) and Zacisze Hospital (other areas).
The agreement was concluded for the period from 20 February 2012 to 31 December 2016 (this in an annex to the long-term agreement, setting forth the agreement value for 2013), and its maximum value during the settlement period, i.e. from 01 January 2013 to 30 June 2013, is PLN 2,565,368.00 net, while from 01 July 2013 to 31 December 2013 it is PLN 2,565,212.00 net.

The agreement provides for the following contractual penalties for Centrum Medyczne ENEL-MED S.A.:

1) In the case of non-performance or improper performance of the agreement due to fault of the Service Provider, the Director of the Branch Fund can impose on the Service Provider a contractual penalty.

2) In the case of issuing prescriptions to unauthorised persons or in unjustified case, the Fund Branch can impose on the Service Provider a contractual penalty equivalent to the undue reimbursement of prices of medicinal product made on the basis of the prescriptions plus statutory interest accrued since the date of the reimbursement.

3) In the case of issuing orders for the supply of medical devices being orthopaedic items or supply of aids financed in whole or in a part by the Fund, to unauthorised persons or in unjustified cases, the Fund Branch can impose on the Service Provider a contractual penalty equivalent to the amount of the undue financing plus statutory interest accrued since the date of the reimbursement.

The Fund is entitled to claim damages exceeding the contractual penalty.

Terms of the agreement, including contractual penalties set forth therein, do not differ from market standards.